...nternational, Inc.,(OTC Bulletin Board: BKYI), a l... wireless public safety, announced today that the ...issuance of a patent for the company,s "Match Temp..." method. , The benefits of the technology p...provide another layer of defense against hackers a...
...e today, it,s easy to forget that a dam and pond s...adison,s Franbrook Farm Research Station in southw...gone, and acres of plants, both native and weedy, ...theless, memories of the dam remain, and by diggin...ers are now unearthing them. Writing in a special ...
..., 2008. The first 5-year forest inventory report f...ailable to the public: California,s Forest Resourc...ysis Report., Here are some key findings from the ...te,s 100 million acres;19 million acres is publicl...terface account for most of the housing growth in ...
Other Biology News:BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Forest inventories in California include more than trees 2Forest inventories in California include more than trees 3(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Ma...m extract, responds to a press release issued on N...garian company for making false and self-serving s...iences. ,, Dr. Hidvegi stated from his office ... that research on Avemar does not apply to AveULTR...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ ...ator in biotechnology for diabetes therapy, and a ...rvices to food, supplement, biotechnology and phar...of Tuesday,s Annual Meeting of Shareholders. ,,...ted (Nasdaq: SPEX ) elected the following members...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therap...t patient in a randomized Phase 2B study of AEG351...development for multiple oncology indications. ,...hase 2 Study of the X-Linked Inhibitor of Apoptosi...ith High-dose Cytarabine and Idarubicin in AML Fol...
(Date:11/19/2009)... InSound is honored by latest aw... Newark, CA (PRWEB) November 16, 2009 -...quo;invisible” hearing aid from InSound Medi...ew Award in the Health category. ...designed to reside deep in the hearing canal for u...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3... Quarter 2007: Total Net Revenue of $627 Million; ... EPS $0.35, Fiscal Year 2007: Total Net Revenue R... $1.27; 2007 Adjusted EPS $1.37, CORONA, Cal... WPI ), a leading specialty pharmaceutical,company... financial results,for its fiscal year ended Decem...
...IA, Md., Feb. 20 Cylex, Inc., today announced the...nical research study in,which the level of cellula...antation using the Company,s proprietary ImmuKnow(... patients that may be at risk for early,acute tran...he first three,months following transplantation., ...
..., Feb. 20 HealthAware, a leading supplier of,inno... today the launch of,VascularAware, the newest dis...rAware is designed to help people who may be at ri...cts nearly 10 million adult Americans,according to...the VascularAware disease module extends the Compa...
Other Biology Technology:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 18New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3HealthAware Introduces Its VascularAware Cardiovascular Disease Module 2GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
GIBCO Versene 1:5;000 (1X); liquid from Invitrogen
Immunochemistry 1 & 2 from Promega
... • This book describes current strategies and...tibodies, the use of antibodies in immunoassays, t... latest ELISA techniques including amplification s...face molecules (cell-ELISA and ELISPOT procedures)...
Biology Products: